Table 3.
Variable |
Group
|
||||||||
---|---|---|---|---|---|---|---|---|---|
Sub-groupgroup |
Case
|
Control
|
|||||||
First visit | Second Visit | P-value | Differences between the first and second visits | First visit | Second visit | P-value | Differences between the first and second visits | ||
Pain | Yes | 35 (77.8 %) | 5 (11.1%) | > 0.001 | -0.66±0.47 (-1)* |
27 (64.3%) | 16 (38.1%) | > 0.001 | -0.26±0.44 (0) * |
No | 10 (22.2 %) | 40 (88.9%) | 15 (35.7%) | 26 (61.9%) | |||||
Swelling | Yes | 26 (57.8 %) | 1 (2.2%) * | > 0.001 | -0.55±0.51 (-1) * |
29 (69.0%) | 22 (52.4%) | 0.016 | 0.16±0.37 (-1) * |
No | 19 (42.2 %) | 44 (97.8%) | 13 (31.0%) | 20 (47.6%) | |||||
Itching | Yes | 38 (84.4 %) | 7 (15.6%) * | > 0.001 | -0.68±0.46 (-1) * |
38 (90.5%) | 35 (83.3%) | 0.25 | -0.07±0.26 (0)* |
No | 7 (15.6 %) | 38 (84.4%) | 4 (9.5%) | 7 (16.7%) | |||||
Secretion | Yes | 39 (86.7%) | 0 (0.0%) * | - | -0.86±0.34 (-1) * |
36 (87%) | 35 (83.3%) | 0.5 | -0.04±0.21 (0) * |
No | 7 (13.3 %) | 45 (100%) | 5 (12.2%) | 7 (16.7%) | |||||
Hearing loss | Yes | 43 (95.6%) | 23 (51.1 %) * | > 0.001 | -0.44±0.5 (0) * |
40 (95.2%) | 40 (95.2% | 1.0 | -0.0±0.0 (0)*-0.0±0.0 (0) * |
No | 2 (4.4%) | 22 (48.9%) | 2 (4.8%) | 2 (4.8%) |
There was a significant difference between the symptoms of the patients in the case and control groups at the level of α=0.05